The efficacy and tolerability of almotriptan 12.5 mg in acute migraine in patients who were poor responders to sumatriptan 50 mg: a randomized, placebo-controlled trial

被引：0

作者：

Diener, HC ^{[1
]}

机构：

[1] Univ Essen Gesamthsch, Dept Neurol, Essen, Germany

来源：

CEPHALALGIA | 2004年 / 24卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：795 / 796

页数：2

共 50 条

[41] Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine:: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials
Dahlöf, CG
Pascual, J
Dodick, DW
Dowson, AJ
CEPHALALGIA, 2006, 26 (04) : 400 - 408
[42] Rizatriptan 5 mg for the acute treatment of migraine in adolescents: A randomized, double-blind, placebo-controlled study
Winner, P
Lewis, D
Visser, WH
Jiang, KH
Ahrens, S
Evans, JK
HEADACHE, 2002, 42 (01): : 49 - 55
[43] Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial
Insull, W
Isaacsohn, J
Kwiterovich, P
Ma, P
Brazg, R
Dujovne, C
Shan, M
Shugrue-Crowley, E
Ripa, S
Tota, R
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2000, 28 (02) : 47 - 68
[44] Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: A double-blind, randomized, placebo-controlled, multicenter study
Lee, B. S.
Kang, B. M.
Yoon, B. K.
Choi, H.
Park, H. M.
Kim, J. G.
MATURITAS, 2007, 57 (04) : 361 - 369
[45] Double-blind, randomized, placebo-controlled study to evaluate the efficacy and tolerability of rizatriptan with acetaminophen for the acute treatment of migraine
Freitag, F. G.
Diamond, M. L.
Skobieranda, F.
Diamond, S.
HEADACHE, 2007, 47 (05): : 749 - 749
[46] Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Lipton, Richard B.
Munjal, Sagar
Brand-Schieber, Elimor
Tepper, Stewart J.
Dodick, David W.
HEADACHE, 2020, 60 (01): : 58 - 70
[47] Relief of acute low back pain with diclofenac-K 12.5 mg tablets: a flexible dose, ibuprofen 200 mg and placebo-controlled clinical trial
Dreiser, RL
Marty, M
Ionescu, E
Gold, M
Liu, JH
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2003, 41 (09) : 375 - 385
[48] EFFICACY, SAFETY, AND TOLERABILITY OF CARISBAMATE 800 AND 1200 MG/DAY AS ADJUNCTIVE THERAPY IN PATIENTS WITH PARTIAL ONSET SEIZURES; RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Halford, J. J.
Ben-Menachem, E.
Kwan, P.
Ness, S.
Schmitt, J.
Eerdekens, M.
Novak, G.
EPILEPSIA, 2010, 51 : 14 - 15
[49] Efficacy of petasites (an extract from petasites rhizone) 50 and 75 mg for prophylaxis of migraine: Results of a randomized, double-blind, placebo-controlled study
Lipton, RB
Gobel, H
Wilks, K
Mauskop, A
NEUROLOGY, 2002, 58 (07) : A472 - A472
[50] Low-Dose (3 Mg) Sumatriptan Injection (DFN-11) Efficacy, Tolerability, and Safety in Episodic Migraine: RESTOR, a Randomized, Double-Blind, Placebo Controlled Study
Landy, S.
Munjal, S.
Brand-Schieber, E.
Rapoport, A.
HEADACHE, 2018, 58 : 78 - 78

← 1 2 3 4 5 →